What's Happening?
The Department of Justice (DOJ) has announced its first healthcare sector declination under the new Corporate Enforcement and Voluntary Self-Disclosure Policy (CEVSDP). Campus Eye Management Holdings, LLC and its subsidiary avoided prosecution for alleged
healthcare fraud by voluntarily self-disclosing and cooperating with the DOJ. The company's founder, Dr. E. Bruce DiDonato, was indicted for conspiracy to commit healthcare fraud and other charges. The CEVSDP, introduced in March 2026, allows for declination of prosecution if companies voluntarily disclose misconduct, cooperate fully, and remediate appropriately. This case marks the second declination under the new framework, emphasizing the DOJ's commitment to encouraging corporate transparency.
Why It's Important?
The DOJ's decision to decline prosecution in this case highlights the potential benefits for companies that choose to self-disclose misconduct. The CEVSDP aims to provide transparency and predictability for businesses, encouraging them to come forward with information about wrongdoing. By offering the possibility of avoiding prosecution, the policy incentivizes companies to maintain robust compliance programs and cooperate with investigations. This approach not only aids in uncovering and addressing corporate misconduct but also promotes a culture of accountability and ethical business practices. As more companies take advantage of this policy, it could lead to increased corporate transparency and reduced instances of fraud.
